Cyteir Therapeutics أخبار Eulerpool

Cyteir Therapeutics إيولربول AFX

أخبار سهم Cyteir Therapeutics

يتابع Cyteir Therapeutics العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Cyteir Therapeutics.

• ٧ مارس ·

  Yahoo
  Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
• ٧ مارس ·

  Thefly.com
  Cyteir Therapeutics announces timeline for voluntarily delisting from Nasdaq
• ٢٠ فبراير ·

  Business Wire
  Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
• ٥ يناير ·

  Thefly.com
  Cyteir Therapeutics downgraded to Underperform at BofA, coverage terminated
• ١ نوفمبر ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 20.00% to 3.06
• ١٢ أكتوبر ·

  Yahoo
  Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile
• ١٢ أكتوبر ·

  Thefly.com
  Cyteir: Cohort of CYT-0851 in combo for ovarian cancer well tolerated
• ١٨ سبتمبر ·

  SeekingAlpha
  Cyteir: Although The Company Is Winding Down, The Lead Asset Had Promise
• ١١ يوليو ·

  Fintel
  Fmr Now Owns 2.33% of Cyteir Therapeutics (CYT)
• ٦ يوليو ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 7.14% to 2.55